Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalini Polymenidou

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
EMBO Molecular Medicine|July 26, 2021
LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathiesMarc Emmenegger, Elena De Cecco, Marian Hruska-Plochan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2013
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degenerationClotilde Lagier-Tourenne, Michael Baughn, Frank Rigo, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2022
Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of <i>C9orf72</i> diseaseMelanie Jambeau, Kevin D Meyer, Marian Hruska-Plochan, et al.
Science (New York, N.Y.)|February 5, 2026
Blocking RAN translation without altering repeat RNAs rescues <i>C9ORF72</i>-related ALS and FTD phenotypesXin Jiang, Laure Schaeffer, Divya Patni, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
EMBO Molecular Medicine|July 26, 2021
LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathiesMarc Emmenegger, Elena De Cecco, Marian Hruska-Plochan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2013
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degenerationClotilde Lagier-Tourenne, Michael Baughn, Frank Rigo, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2022
Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of <i>C9orf72</i> diseaseMelanie Jambeau, Kevin D Meyer, Marian Hruska-Plochan, et al.
Science (New York, N.Y.)|February 5, 2026
Blocking RAN translation without altering repeat RNAs rescues <i>C9ORF72</i>-related ALS and FTD phenotypesXin Jiang, Laure Schaeffer, Divya Patni, et al.
Pageof 8